Abstract:Extracellular vesicles (EVs) are involved in the pathogenesis of neoplastic diseases. Their role in mediating drug resistance has been widely described in several types of cancers, including melanoma. EVs can mediate drug resistance through several different mechanisms, such as drug-sequestration, transfer of pro-survival proteins and RNA, induction of cancer stem cell-like features and interaction with cells of the tumor microenvironment and immune-system. Melanoma is a highly immunogenic tumor originating from the malignant transformation of melanocytes. Several therapeutic strategies currently used in the treatment of melanoma and the combination of BRAF and MEK-inhibitors, as well as immune check-point inhibitors (ICI), have consistently improved the overall survival time of melanoma patients. However, the development of resistance is one of the biggest problems leading to a poor clinical outcome, and EVs can contribute to this. EVs isolated from melanoma cells can contain “sequestered” chemotherapeutic drugs in order to eliminate them, or bioactive molecules (such as miRNA or proteins) that have been proven to play a crucial role in the transmission of resistance to sensitive neoplastic cells. This leads to the hypothesis that EVs could be considered as resistance-mediators in sensitive melanoma cells. These findings are a pivotal starting point for further investigations to better understand EVs’ role in drug resistance mechanisms and how to target them. The purpose of this review is to summarize knowledge about EVs in order to develop a deeper understanding of their underlying mechanisms. This could lead to the development of new therapeutic strategies able to bypass EV-mediated drug-resistance in melanoma, such as by the use of combination therapy, including EV release inhibitors.

The Roles of Extracellular Vesicles in Malignant Melanoma

The Role of Extracellular Vesicles in Melanoma Progression

Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy

Immunomodulatory effects of immune cell-derived extracellular vesicles in melanoma

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy

Extracellular vesicle-derived non-coding RNAs in remodeling melanoma

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond

Advancements in melanoma immunotherapy: the emergence of Extracellular Vesicle Vaccines

Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials

Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles

Extracellular Vesicles (evs) in Tumor Diagnosis and Therapy

Extracellular vesicles and the regulation of tumor immunity: Current progress and future directions

Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression